These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 39239735

  • 1. Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin.
    Matsumura T, Kitamura M, Amatsu S, Yamaguchi A, Kobayashi N, Yutani M, Fujinaga Y.
    Microbiol Immunol; 2024 Oct; 68(10):348-358. PubMed ID: 39239735
    [Abstract] [Full Text] [Related]

  • 2. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T, Amatsu S, Misaki R, Yutani M, Du A, Kohda T, Fujiyama K, Ikuta K, Fujinaga Y.
    Toxins (Basel); 2020 May 07; 12(5):. PubMed ID: 32392791
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y, Barash JR, Lou J, Conrad F, Marks JD, Arnon SS.
    J Infect Dis; 2016 May 15; 213(10):1606-14. PubMed ID: 26936913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C, Avril A, Chahboun S, Tierney R, Bak N, Miethe S, Mazuet C, Popoff MR, Thullier P, Hust M, Pelat T, Sesardic D.
    MAbs; 2015 May 15; 7(6):1161-77. PubMed ID: 26381852
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.
    Liu Y, Liu X, Chen W, Yu Y, Meng J, Wang J.
    Front Immunol; 2024 May 15; 15():1469919. PubMed ID: 39315101
    [Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.
    Jiang Y, Wang R, Guo J, Cheng K, Chen L, Wang X, Li Y, Du P, Gao C, Lu J, Yu Y, Yang Z.
    Front Immunol; 2024 May 15; 15():1380694. PubMed ID: 38779676
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R, Forsyth CM, LaPorte SL, Geren IN, Smith LA, Marks JD.
    J Mol Biol; 2007 Jan 05; 365(1):196-210. PubMed ID: 17059824
    [Abstract] [Full Text] [Related]

  • 14. Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
    Miethe S, Mazuet C, Liu Y, Tierney R, Rasetti-Escargueil C, Avril A, Frenzel A, Thullier P, Pelat T, Urbain R, Fontayne A, Sesardic D, Hust M, Popoff MR.
    PLoS One; 2016 Jan 05; 11(8):e0161446. PubMed ID: 27560688
    [Abstract] [Full Text] [Related]

  • 15. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
    Derman Y, Selby K, Miethe S, Frenzel A, Liu Y, Rasetti-Escargueil C, Avril A, Pelat T, Urbain R, Fontayne A, Thullier P, Sesardic D, Lindström M, Hust M, Korkeala H.
    Toxins (Basel); 2016 Sep 12; 8(9):. PubMed ID: 27626446
    [Abstract] [Full Text] [Related]

  • 16. Selection and characterization of a human monoclonal neutralizing antibody for Clostridium Botulinum neurotoxin serotype B.
    Zhou H, Zhou B, Pellett S, Johnson EA, Janda KD.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):662-4. PubMed ID: 19112017
    [Abstract] [Full Text] [Related]

  • 17. Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.
    Tremblay JM, Vazquez-Cintron E, Lam KH, Mukherjee J, Bedenice D, Ondeck CA, Conroy MT, Bodt SML, Winner BM, Webb RP, Ichtchenko K, Jin R, McNutt PM, Shoemaker CB.
    Toxins (Basel); 2020 Sep 24; 12(10):. PubMed ID: 32987745
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR, Tepp WH, Pier CL, Bradshaw M, Ho M, Wilson BA, Fritz RB, Johnson EA, Barbieri JT.
    Infect Immun; 2005 Oct 24; 73(10):6998-7005. PubMed ID: 16177380
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
    Chen C, Wang S, Wang H, Mao X, Zhang T, Ji G, Shi X, Xia T, Lu W, Zhang D, Dai J, Guo Y.
    PLoS One; 2012 Oct 24; 7(8):e43845. PubMed ID: 22952786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.